For the Inventor, By the Inventor

Enter assignee name

San Antonio, TX, United States of America

Osteoscreen, Inc.

USPTO Granted Patents = 28

EPO Patents = 1

Forward Citations = 1,121

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Gregory R Mundy (24 out of 40 patents)

I Ross Garrett (12 out of 13 patents)

Kirk G Robbins (12 out of 19 patents)

4. Nand Baindur (12 out of 30 patents)

5. Charles R Petrie (10 out of 26 patents)

6. Mark W Orme (9 out of 68 patents)

7. Jorge Gianny Rossini (7 out of 10 patents)

8. Maria Kontoyianni (5 out of 7 patents)

9. Scott M Harris (3 out of 13 patents)

10. Gloria Gutierrez (3 out of 4 patents)

11. Virender M Labroo (2 out of 25 patents)

12. Wolfgang E Gallwitz (2 out of 2 patents)

13. Robert R West (2 out of 16 patents)

14. Theresa Martinez (2 out of 10 patents)

15. Shirley R Gasper (2 out of 6 patents)

28 patents: Sort by Forward Citations

1. 8299046 - Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth (2012-10-30),

2. 7678395 - Stimulation of hair growth by isoginkgetin (2010-03-16),

3. 7288535 - Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (2007-10-30),

4. 7223554 - Inhibitors of proteasomal activity for stimulating hair growth (2007-05-29),

5. 6958220 - Inhibitors of proteasomal activity for stimulating hair growth (2005-10-25),

6. 6902721 - Inhibitors of proteasomal activity for stimulating bone growth (2005-06-07),

7. 6884769 - Inhibitors of proteasomal activity for stimulating hair growth (2005-04-26),

8. 6838436 - Inhibitors of proteasomal activity for stimulating bone growth (2005-01-04),

9. 6838252 - Inhibitors of proteasomal activity for stimulating hair growth (2005-01-04),

10. 6656904 - Inhibitors of proteasomal activity for stimulating bone and hair growth (2003-12-02),

11. 6492333 - Treatment of myeloma bone disease with proteasomal and NF-&kgr;B activity inhibitors (2002-12-10),

12. 6462019 - Inhibitors of proteasomal activity and production for stimulating bone growth (2002-10-08),

13. 6413998 - Compositions and methods for treating bone deficit conditions (2002-07-02),

14. 6410521 - Nutritional supplements for stimulating bone growth (2002-06-25),

15. 6410512 - Inhibitors of proteasomal activity for stimulating hair growth (2002-06-25),

Osteoscreen, Inc. is a leading biotech company specializing in the development of innovative screening technologies for osteoporosis detection. Our mission is to provide accurate and cost-effective solutions for early diagnosis and treatment of osteoporosis, a prevalent bone disorder affecting millions of people worldwide. With a team of experienced scientists and cutting-edge research facilities, we strive to revolutionize the field of osteoporosis diagnosis, empowering healthcare professionals to make informed decisions and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

28 Patents

#21 in San Antonio, TX

#669 in Texas

#11,597 in US

#22,547 in the World

San Antonio, TX, United States of America

Osteoscreen, Inc.

Forward Citations = 1,121

30 inventors:

Gregory R Mundy (24 out of 40 patents)

I Ross Garrett (12 out of 13 patents)

Kirk G Robbins (12 out of 19 patents)

4. Nand Baindur (12 out of 30 patents)

5. Charles R Petrie (10 out of 26 patents)

Please report any incorrect information to support@idiyas.com

Loading…